Cargando…
Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non‐hypertensive Alzheimer's patients
INTRODUCTION: Acetylcholinesterase inhibitors (AChEIs) are commonly used to treat mild to moderate cases of Alzheimer disease (AD). To the best of our knowledge, there has been no study estimating the risk of bleeding and cardiovascular events in patients with non‐hypertensive AD. Therefore, this st...
Autores principales: | Al‐Hamed, Faez Saleh, Kouniaris, Stamatis, Tamimi, Iskandar, Lordkipanidzé, Marie, Madathil, Sreenath Arekunnath, Kezouh, Abbas, Karp, Igor, Nicolau, Belinda, Tamimi, Faleh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377777/ https://www.ncbi.nlm.nih.gov/pubmed/34458554 http://dx.doi.org/10.1002/trc2.12184 |
Ejemplares similares
-
Effect of acetylcholinesterase inhibitors on post-surgical complications and mortality following a hip fracture: a cohort study
por: Tamimi, I., et al.
Publicado: (2017) -
Addendum: Effect of acetylcholinesterase inhibitors on post-surgical complications and mortality following a hip fracture: a cohort study
por: Tamimi, I., et al.
Publicado: (2019) -
Postoperative Administration of the Acetylcholinesterase Inhibitor, Donepezil, Interferes with Bone Healing and Implant Osseointegration in a Rat Model
por: Al-Hamed, Faez Saleh, et al.
Publicado: (2020) -
Lung Cancer Pre-Diagnostic Pathways from First Presentation to Specialist Referral
por: Khare, Satya Rashi, et al.
Publicado: (2021) -
Regenerative Effect of Platelet Concentrates in Oral and Craniofacial Regeneration
por: Al-Hamed, Faez Saleh, et al.
Publicado: (2019)